Alex Bataller Torralba, MD, PhD
Department of Leukemia, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2022 | University of Barcelona, Barcelona, ES, Translational Medicine, PhD |
| 2014 | University of Barcelona, Barcelona, ES, MD |
Postgraduate Training
| 2022-2024 | Fellowship, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2021-null | Master's Degree, Bioinformatics and Biostatistics, Universitat Oberta de Catalunya, Barcelona |
| 2019-2020 | Master's Degree, Molecular Oncology, Rey Juan Carlos University, Madrid |
| 2018-2019 | Masters' Degree, Hematopoietic stem cell transplantation, University of Valencia, Valencia |
| 2015-2019 | Fellow, Hematology and Hemotherapy, Hospital Clinic of Barcelona, Barcelona |
Licenses & Certifications
| 2025 | Faculty Temporary License |
Experience & Service
Faculty Academic Appointments
Pre-doctoral Researcher, August Pi i Sunyer Biomedical Research institute (IDIBAPS) and Josep Carreras Leukemia Research Institute, Barcelona, 2019 - 2022
Administrative Appointments/Responsibilities
Chief fellow, Department of Leukemia Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2024
Chief resident, Department of Hematology Residency Program, Hospital Clinic de Barcelona, Barcelona, 2018 - 2019
Elected member of the Education Commission, Hospital Clinic de Barcelona, Barcelona, 2017 - 2019
Other Professional Positions
Hematology and Immunology lecturer, Academia de estudios AMIR, Madrid, 2016 - 2022
Student Mentor, Academia de estudios AMIR, Madrid, 2014 - 2015
Editorial Activities
Reviewer, “Annals of Hematology” journal, 2024 - 2024
Reviewer, “Leukemia and Lymphoma” journal, 2024
Reviewer, “BMC Cancer” journal, 2024 - 2024
Reviewer, “Cancer” journal, 2023 - 2024
Reviewer, “Clinical Lymphoma, Myeloma and Leukemia” journal, 2023
Reviewer, “European Journal of Hematology” journal, 2023
Reviewer, “Clinical Reviews in Oncology/Hematology” journal, 2023 - 2024
Reviewer, “Leukemia Research” journal, 2023 - 2024
Reviewer, “Bone Marrow Transplantation” journal, 2020
Honors & Awards
| 2024 - Present | Best Research Fellow, Department of Leukemia, The University of Texas MD Anderson Cancer Center |
| 2024 | Clinical Resident/Fellow Excellence Award for Teamwork, MD Anderson Cancer Center |
| 2020 | MSD Grant for the most outstanding resident of the promotion, Hospital Clinic de Barcelona, Barcelona, Spain |
| 2019 | Investigation grant, Spanish Foundation of Hematology and Hemotherapy, Valencia, Spain |
| 2019 | Excellence scholarship, Spanish Association against Cancer (AECC), Madrid, Spain |
| 2018 | Emili Letang Residency Award, Hospital Clínic de Barcelona, Barcelona, Spain |
| 2018 | Bolsa de Viaje, Spanish Society of Hematology and Hemotherapy, Madrid, Spain |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2024. Genetic dynamics and outcomes of AML at first relapse Hematology/Oncology Grand Rounds. Invited. Chicago, IL, US.
International Presentations
- 2024. Understanding and facing R/R AML. Invited. II Annual Meeting of the CETLAM group. Barcelona, ES.
- 2023. Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 mutations Update in diagnosis and management of acute myeloid leukemia. Invited. Barcelona, ES.
Formal Peers
- Design and validation of a CD123-directed CAR-T model for relapse/refractory acute myeloid leukemia. Barcelona, ES.
- Immunotherapy in acute myeloid leukemia. Barcelona, ES.
- Anaplastic lymphoma with peripheral blood expression. Barcelona, ES.
- KMT2A-Partial tandem duplications (MLL-PTD) in AML. Barcelona, ES.
- ALK negative Anaplastic lymphoma. Barcelona, ES.
- CLL progression and transformation in the ibrutinib era. Barcelona, ES.
- Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL). Barcelona, ES.
Grant & Contract Support
| Date: | 2020 - 2022 |
| Title: | Investigation grant FEHH |
| Funding Source: | Spanish Foundation of Hematology and Hemotherapy |
| Role: | Predoctoral researcher |
| Date: | 2019 - 2020 |
| Title: | Emili Letang Residency Award |
| Funding Source: | Hospital Clinic of Barcelona |
| Role: | Predoctoral researcher |
Selected Publications
Peer-Reviewed Articles
- Guijarro, F, Bataller Torralba, A, Díaz-Beyá, M, Garrido, A, Coll-Ferrà, C, Vives, S, Salamero, O, Valcárcel, D, Tormo, M, Arnan, M, Sampol, A, Castaño-Díez, S, Martinez, C, Suárez-Lledó, M, Fernández-Avilés, F, Hernández-Boluda, JC, Ribera, JM, Rovira, M, Brunet, S, Sierra, J, Esteve, J. Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan. Bone marrow transplantation 57(8):1304-1312, 2022. e-Pub 2022. PMID: 35643942.
- Bataller Torralba, A, Garrido, A, Guijarro, F, Oñate, G, Díaz-Beyá, M, Arnan, M, Tormo, M, Vives, S, de Llano, MQ, Coll, R, Gallardo, D, Vall-Llovera, F, Escoda, L, Garcia-Guiñon, A, Salamero, O, Sampol, A, Merchan, B, Bargay, J, Castaño-Díez, S, Esteban, D, Oliver-Caldés, A, Rivero, A, Mozas, P, López-Guerra, M, Pratcorona, M, Zamora, L, Costa, D, Rozman, M, Nomdedeu, J, Colomer, D, Brunet, S, Sierra, J, Esteve, J. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia. Blood Advances 6(4):1193-1206, 2022. e-Pub 2022. PMID: 34911079.
- Oñate, G, Bataller Torralba, A, Garrido, A, Hoyos, M, Arnan, M, Vives, S, Coll, R, Tormo, M, Sampol, A, Escoda, L, Salamero, O, Garcia, AM, Bargay, J, Aljarilla, A, Nomdedeu, J, Esteve, J, Sierra, J, Pratcorona, M. Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Advances 6(3):882-890, 2022. e-Pub 2022. PMID: 34516636.
Review Articles
- Perez-Amill, L, Bataller Torralba, A, Delgado, J, Esteve, J, Juan, M, Klein-González, N. Advancing CART therapy for acute myeloid leukemia. Frontiers in immunology 14, 2023. e-Pub 2023. PMID: 38098489.
- Molina, O, Bataller Torralba, A, Thampi, N, Ribera, J, Granada, I, Velasco, P, Fuster, JL, Menendez, P. Near-haploidy and low-hypodiploidy in b-cell acute lymphoblastic leukemia. Cancers 14(1), 2022. e-Pub 2022. PMID: 35008193.
Patient Reviews
CV information above last modified October 08, 2025